Cytochromes
P450 (P450s) and their genetic variants in humans are
important drug-metabolizing enzymes partly accounting for interindividual
variations in drug metabolism and toxicity. However, these genetic
variants in P450s have not been fully investigated in cynomolgus macaques,
a nonhuman primate species widely used in toxicological studies. In
this study, genetic variants found in cynomolgus CYP1A1, CYP2C9 (formerly
CYP2C43), CYP2C19 (CYP2C75), and CYP3A4 (CYP3A8) were assessed on
functional importance. Resequencing of CYP1A1 in
cynomolgus macaques found 18 nonsynonymous variants, of which M121I
and V382I were located in SRSs, domains potentially important for
P450 function. By further analyzing these two variants, V382I was
significantly associated with lower drug-metabolizing activities in
the liver for the heterozygotes than the wild types. Similarly, the
heterozygotes or homozygotes of CYP2C9 variants (A82V and H344R) and
CYP2C19 variant (A490V) showed significantly lower drug-metabolizing
activities in the liver than the wild types. Moreover, the homozygotes
of CYP3A4 variant (S437N) showed significantly higher activities than
the wild type in the liver. Kinetic analyses using recombinant proteins
revealed that CYP2C9 variants (A82V and H344R) showed substantially
lower K
s values than the wild type,
although CYP1A1 variant (V382I) showed kinetic parameters similar
to the wild type. Likewise, CYP2C19 variant (A490V) showed substantially
a lower V
max/K
m value than the wild type, whereas CYP3A4 variant (S437N)
showed a higher V
max/K
m value than the wild type. These results suggest the
toxicologically functional importance of CYP2C9 variants (A82V and
H344R), CYP2C19 variant (A490V), and CYP3A4 variant (S437N) for hepatic
drug metabolism in cynomolgus macaques.